Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Vertex Pharmaceuticals announced today a reimbursement agreement with the Italian Medicines Agency AIFA for eligible transfusiondependent beta thalassemia TDT and severe sickle cell disease SCD patients
Illumina Incand Nashville Biosciences LLC today announced Alnylam Pharmaceuticals Inc NASDAQ ALNY Alnylam as a member of the Alliance for Genomic Discovery AGD Alnylam a pioneer in RNA interference
The worlds first therapeutic drug to be equipped with NovalGens pioneering AutoRegulation AR technology has been approved for evaluation in the clinic by the UKs Medicine and Healthcare Products Regulatory Agency MHRA
Alteogen Inc announced today that the European Commission EC has granted marketing authorization for EYLUXVI code name ALTL an Eylea biosimilar codeveloped by its subsidiary Alteogen Biologics
MabwellBioscience Co Ltd and Aditum Bio today announced the launch of Kalexo Bio a new company formed in conjunction with an exclusive global license agreement to develop MW a novel dualtarget siRNA candidate for lipid management in patients with dys...
Celltrion Pharm a South Korean biopharmaceutical firm said on September that it has inked a strategic trilateral agreement with a multinational syringe manufacturer Becton Dickinson France SAS BD and its Korean branch BD Korea The signing ceremony t...
NurExone Biologic Inca biopharmaceutical innovator in exosomebased regenerative therapies is pleased to announce that its US subsidiary ExoTop Inc ExoTop is planning to establish its first US commercial exosome production facility in Indianapolis Ind...
The Berlin Institute of Health at Charit BIH and ProBioGen today announced a major collaboration to manufacture materials for gene and cell therapies The partnership was unveiled at the groundbreaking ceremony
Li Lilly and Company NYSE LLY today announced that it plans to build a billion manufacturing facility just west of Richmond Virginia in Goochland County The new site will be the companys first dedicated fully integrated active pharmaceutical ingredi...
Optune Lua is now approved for use concurrently with PDPDL inhibitors in adult patients with unresectable advancedrecurrent NSCLC who progressed on or after platinumbased chemotherapy
